PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Curr Opin Obstet Gynecol. Author manuscript; available in PMC 2010 February 1.
Published in final edited form as:
PMCID: PMC2636962
NIHMSID: NIHMS90120

Diet and Breast Cancer Prognosis: Making Sense of the WHEL and WINS Trials

Abstract

Purpose of Review

To clarify the role of dietary pattern on prognosis in breast cancer survivors.

Recent Findings

Observational trials show mixed results that do not strongly support an independent role for dietary pattern in prognosis. WINS and WHEL are two large randomized controlled trials that address this question. The Interventions from both studies achieved significant reductions in energy from fat and the WHEL Study achieved large increases in vegetables, fruit, and fiber. WINS examined postmenopausal women only and reported a not-quite-significant improved prognosis for women in the intervention group, with the benefit focused on ipsilateral localized recurrences but little improvement in the most important distal recurrences. This review considers only WHEL postmenopausal women to aid a direct comparison with WINS. The WHEL Study reported a convincing lack of association between diet and prognosis. However, a secondary analysis suggests that the dietary intervention reduced distal recurrences among the sub-group without hot flashes at baseline.

Summary

There is no convincing evidence that changing dietary pattern following breast cancer diagnosis will improve prognosis for most women with early stage breast cancer. However, it would appear to be important for some sub-groups. Further investigation of mechanisms for such selective action is needed.

Keywords: breast cancer prognosis, dietary pattern, randomized trials

INTRODUCTION

Breast cancer is one of the most common cancers among women in developed countries and significant advances in early detection and treatment have led to high 10-year survival rates and large prevalent survivor populations. Clinical outcome among women diagnosed with apparently similar cancers varies considerably, and does not appear to be explained by treatment differences. Laboratory studies have identified multiple bioactive constituents in foods that appear to either promote carcinogenesis or protect against it. As a result, there is considerable interest in the question of whether dietary pattern can influence a woman’s prognosis following breast cancer.

Prospective observational studies, or cohort studies, measure the dietary component or pattern and then monitor prognosis over time. These association studies do not provide sufficient evidence to conclude that changing dietary pattern would alter prognosis. The “gold standard” studies are randomized trials in which some participants are assigned to make a major dietary change. Several prospective observational studies have investigated the link between dietary pattern and breast cancer prognosis, and to date two randomized clinical trials have tested this association.

Observational studies

However, most dietary studies are compromised by measurement errors in the commonly used self-reported dietary patterns [1] and there are few proven biomarkers of exposure to validate self-report. The extent of these measurement errors has been highlighted by two separate studies that have demonstrated that the self-report method used changes the study outcome [2, 3]. Another study showed an effect with a biomarker that was not seen with self-reported intake [4, 5].

Reviews of the observational studies of diet and breast cancer prognosis have identified 14 studies since 1990 [6, 7, 8*,921]. However, many of these studies measured pre-breast cancer dietary pattern shortly following diagnosis with breast cancer. As diets commonly change following diagnosis [22], dietary recalls over extended periods that include diagnosis have additional measurement problems and are excluded from this review.

In 1994, the Canadian National Breast Screening Study reported 5-year survival data from the subsample of 678 breast cancer cases that had completed a diet history prior to diagnosis [23]. In this study, lower saturated fat intake (but not intake of total fat or oleic acid) was associated with survival and women in the highest versus lowest quartiles of intake of beta carotene and vitamin C from food sources appeared protected.

The Nurses’ Health Study is a well known long-term investigation of a cohort of female registered nurses. Holmes et al [15] reported on a subsample (n=1982) who were diagnosed with breast cancer from 1976–1990 and completed a dietary assessment in the post diagnosis period and followed through 1994. Consumption of fruit, red meat, or grain-based products was not associated with either all-cause mortality or breast carcinoma death. However, among women with metastatic cancer, consumption of vegetables, carotenoids and fiber had lower mortality rates. Kroenke et al [17] reported on the 2619 nurses who were diagnosed from 1982–1998 and completed a dietary questionnaire at least 1 year post diagnosis. Over a median 9 years of follow-up, 9% of participants died from breast cancer. Using factor analysis, researchers identified two dietary patterns: one in which vegetables, fruit, whole grains, low fat dairy, poultry, fish and fiber consumption increased across quintiles (prudent dietary pattern) and the other in which consumption of refined grains, red meat, processed meat, high fat dairy, saturated fat and dessert increased across quintiles (western dietary pattern). Neither dietary pattern was related to breast cancer mortality. However, the prudent dietary pattern reduced and western dietary pattern increased deaths from other causes. Thus, the no-association result for dietary fat consumption was consistent across these two overlapping cohorts, but the conclusions for a mortality association with the consumption of vegetables, fruit and fiber were not.

The Women’s Healthy Eating and Living (WHEL) Study reported observational data from women randomized to the comparison group. Dietary assessment occurred an average of 2 years post diagnosis and dietary patterns were validated with a plasma carotenoid concentration, the accepted biomarker of vegetable and fruit intake. The first report [19] focused on 205 women who had a breast cancer event prior to June 2004 (average of 5 years follow-up) and identified those in the lowest baseline tertile (compared to all others) of circulating carotenoid concentrations as having an approximate 40% increased risk. The second report [24**] focused on overall mortality and included follow-up through December 2005. No association was found for energy from fat. Vegetable-fruit consumption and physical activity were weakly associated by themselves but there was an interaction between them with the combination of vegetable-fruit intake (at least 5 vegetables and fruits/day) and physical activity (equivalent to walking briskly for 30 minutes, 6 days a week) reduced the risk of dying from breast cancer by half, regardless of weight, although fewer obese women were physically active with a healthy dietary pattern (16% vs. 30%). The effect was stronger in women who had hormone receptor–positive cancers.

Comparing WHEL and WINS randomized trials

Both the Women’s Intervention Nutrition Study (WINS) and the WHEL Study randomized women who had been diagnosed with early stage breast cancer in the United States during the 1990s, before the widespread use of aromatase inhibitors. Both studies enrolled women with tumors ≥ 1 cm, but there were three important differences in the eligibility criteria. The first was age: WINS enrolled postmenopausal women aged 48–79 years at diagnosis whereas WHEL enrolled women aged 18–70 years. However, to compare studies it is possible to categorize WHEL participants by menopausal status (Table 1). Both the WHEL (n=2448) and the WINS (n=2437) studies had almost equivalently-sized populations of postmenopausal women.

Table 1
Cancer characteristics of WINS and WHEL Study populations

The second difference was the time between diagnosis and enrollment. WINS enrolled women within 1 year of diagnosis, whereas the WHEL Study enrolled women within 4 years of diagnosis. (Table 1) Thus, the WHEL Study undersampled the population who would recur within 4 years of diagnosis and is really a study of breast cancer events between 2 and 10 years from diagnosis [25]. WINS on the other hand is focused much more on breast cancer events within the first 5 years from diagnosis. The third difference was that WINS excluded women with worse prognoses (based on tumor size and nodes), thus WHEL postmenopausal women had more advanced cancer characteristics at diagnosis. Over half of WINS participants were stage 1 compared to just over a third of the WHEL sample, and 25% of WHEL women were stage IIB or IIIA compared to only 10% of WINS. In both studies, about one fifth of postmenopausal women had ER negative tumors at diagnosis.

Despite the above differences in cancer characteristics, both studies recruited breast cancer survivors from similar populations. Socio-demographic characteristics of WINS and WHEL participants were markedly similar (Table 2) in terms of age (55 vs 58 years), race (85% were Caucasian) and education (almost 50% college graduates). Approximately 27% of postmenopausal participants in both studies were obese and the mean energy intake from fat was 29%.

Table 2
Comparison of WINS and WHEL Study populations

These WINS and WHEL comparisons include WHEL participants who were pre and peri menopausal. These women were younger, more highly educated and less likely to be obese. (Table 2) They were also more likely to be recruited in the first year and more likely to be ER negative. (Table 1)

The effect of the WINS intervention

Both the WINS and the WHEL studies used sets of four 24 hour recalls to assess current dietary pattern at multiple points in time. The WINS intervention focused on reducing fat intake to 15% of energy. At 1 year, the intervention reported a 9% between-group difference in dietary fat intake [26**] (Table 3). While it appeared that this between-group difference was maintained through 5 years, the low response rate for dietary assessments makes this result questionable (year 3 response ~70%; year 5 response ~40%). In reporting a completers-only analysis, the authors assumed that diets of the large proportion of nonrespondents were similar to the diets of the respondents – a very questionable assumption. Using a more conservative assumption (that nonrespondents didn’t lower their fat intake), an estimate of the between-group difference is ~6% at year 3 and ~3.5% at year 5. WINS also reported that the intervention group lost weight, resulting in a between group difference of 2.3 kg in year 1 (conservative assumption= ~1.6 kg) to 2.7 kg in year 5 (conservative assumption = ~1.1 kg).

Table 3
Change achieved by WINS intervention

The effect of the WHEL Study intervention

The WHEL Study intervention encouraged women to adopt a daily dietary pattern including 5 vegetable servings, 16 oz of vegetable juice, 3 fruit servings, 30g of fiber and 20% energy from fat. Unlike WINS, there was only a small decline in completion rates for dietary assessment and 85% were assessed at year 6 (Table 4). The study has presented dietary change data in two ways: using a completers only analysis [24**] as well as with the conservative assumption that nonresponders did not change their dietary pattern [27].

Table 4
Change achieved by WHEL Study intervention

To compare dietary change with WINS, we present the completers only data in Table 4 [24**]. The intervention was associated with a between-group difference of 4.7 vegetable-fruit servings/d at 1 year which decreased to 3 servings/d by 6 years. The between-group difference for fiber consumption was 8 g/d at 1 year, decreasing to 5g/d at year 6. The between-group difference in energy from fat was 5.7% at 1 year, decreasing to 3.5% at 6 years, similar to the conservative estimate of the WINS intervention effect. Body weight changed little over 6 years. The conservative analysis concluded that, at 4years, the relative between-group differences were 65% for vegetables (including juice), 25% for fruit, 30% for fiber, and 13% for energy from fat.

Study outcomes: WINS vs. WHEL

The WINS and the WHEL studies have reported conflicting results. WINS assessed the summary variable “any breast cancer event” for their analysis and the 2.6% between-group difference was borderline significant in the planned stratified log rank test (p=0.077) although statistically significant in the multivariate Cox model (p=0.034) [26**]. Further, an exploratory analysis suggested that the between-group differences in breast cancer events might be confined to the 20% of the sample with initial tumors that were ER negative, however, the interaction between dietary intervention and hormone receptor status was not statistically significant.

The WHEL Study [24**] reported no between-group differences in either any breast cancer event (adjusted Hazard Ratio= 0.63) or in overall mortality (HRadj= 0.43). Additionally, for breast cancer events, the likelihood ratio tests for baseline dietary pattern by study group interaction were not significant for vegetable-fruit, fiber or energy from fat. However, for overall mortality, the likelihood ratio test was significant for quartiles of energy from fat (p=0.04), although the effect seemed to be in only the second quartile of baseline energy from fat and the intervention group difference was not in a protective direction. Further, hormone receptor status did not differ between groups (p=0.85).

Given the considerable similarities between these randomized trials, the marked difference in these findings require further investigation. Table 5 presents details of the different study outcomes for postmenopausal women. As expected from the initial cancer characteristics (Table 1) and the longer follow-up period, WHEL reported more study events than WINS (Table 5) and particularly more distal recurrences that Tang [28] has argued are the most important study outcome for patients with a pre-existing breast cancer diagnosis. The size of the between group difference in these distal recurrences was not that different for both of these studies (WINS = −1.1, WHEL = −0.9).

Table 5
Comparison of cancer outcomes in WINS and WHEL Study populations

The difference in the studies occurred in the between-group differences in the proportion of women who had local recurrences and new primary breast cancer events (WINS = −1.3%, WHEL = +0.5%), and, in particular, the WINS group effect was among women who had a lumpectomy for their initial cancer and had an ipsilateral breast cancer recurrence during the follow-up period (C= 2.1%; I=1.1%). It is possible that the lack of a WHEL effect in this sub-population of women reflected the fact that WHEL underestimated events in the first few years from diagnosis. Another plausible explanation is that this finding is an artifact, particularly as the main hypothesis was only marginally statistically significant.

WHEL study secondary analysis

The initial WHEL Study protocol [25] postulated that diet could affect prognosis by reducing circulating estrogen concentrations. The study’s nested case-control analysis showed that women with higher circulating estradiol concentrations at baseline were less likely to report hot flashes at that time and more likely to have a secondary cancer event during the follow-up period [29*]. In two separate studies, early stage breast cancer survivors who did not report hot flashes shortly after treatment were ~30% more likely to have additional breast cancer events [30*, 31]. Given that the WHEL Study intervention has been shown to reduce circulating estrogen concentrations [32], the study undertook a secondary analysis to see if an intervention effect may have been limited to this group of women who did not report hot flashes at baseline [33**].

About one third of WHEL participants (n=900) were in the subgroup who did not report hot flashes at baseline (HF-) [24**, 33**]. The intervention participants in this HF- subgroup had a similarly large change in dietary pattern (vegetables, fruit, fiber, and energy from fat) over the course of the study to that seen in the overall intervention group. Among the comparison HF- subgroup, 76.4% of the comparison group and 83.9% of the intervention group remained breast cancer free. (p=0.002) This effect was almost entirely restricted to the distal recurrence group (C=15.9%, I=9.4%), and the ~60% lower event rate in the intervention group was not explained by other variables in a series of sensitivity analyses [33**]. This effect did not differ significantly by hormone receptor status (p=0.63).

CONCLUSIONS

The evidence from prospective observational studies is mixed particularly for vegetable-fruit-fiber consumption though more consistently negative for fat consumption. Two randomized trials have been reported, WINS focused on the dietary fat hypothesis while WHEL focused on a plant-based dietary pattern that included a reduction in dietary fat. WHEL reported that the comprehensive dietary change had no effect on prognosis, whereas WINS reported a marginal positive effect from changing fat.

This review compares postmenopausal participants from these studies focusing on what might explain the different results. Both studies indicate that dietary pattern is not a strong “across the board” predictor of prognosis. Each study suggests that the dietary pattern may be effective within a subgroup of people. Further investigation of sub-groups is required particularly focused on population evidence of the mechanism by which these dietary patterns may impact prognosis.

Acknowledgments

The author wishes to thank the WHEL Study Group for providing partitioned study data for use in this paper. The author would also like to thank Sheila Kealey, MPH and Christine Hayes, MA for assistance in manuscript preparation.

References

1. Natarajan L, Flatt SW, Sun X, et al. Validity and systematic error in measuring carotenoid consumption with dietary self-report instruments. Am J Epidemiol. 2006;163(8):770–778. [PubMed]
2. Bingham SA, Luben R, Welch A, et al. Are imprecise methods obscuring a relation between fat and breast cancer? Lancet. 2003;362(9379):212–214. [PubMed]
3. Freedman LS, Potischman N, Kipnis V, et al. A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int J Epidemiol. 2006;35(4):1011–1021. [PubMed]
4. Toniolo P, Van Kappel AL, Akhmedkhanov A, et al. Serum carotenoids and breast cancer. Am J Epidemiol. 2001 Jun 15;153(12):1142–1147. [PubMed]
5. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables and risk of breast cancer: A pooled analysis of cohort studies. JAMA. 2001;285(6):769–776. [PubMed]
6. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: A review of the evidence. J Clin Oncol. 2002;20(15):3302–3316. [PMC free article] [PubMed]
7. Kellen E, Vansant G, Christiaens MR, et al. Lifestyle changes and breast cancer prognosis: A review. Breast Cancer Res Treat. 2008 Apr 4;
*8. Pierce JP, Stefanick ML, Flatt SW, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol. 2007;25(17):2345–2351. This paper is a prospective observational study highlighting the interaction between dietary pattern, physical activity and obesity as predictors of mortality. [PMC free article] [PubMed]
9. Boyapati SM, Shu XO, Ruan ZX, et al. Soyfood intake and breast cancer survival: A followup of the shanghai breast cancer study. Breast Cancer Res Treat. 2005;92(1):11–17. [PubMed]
10. Holm LE, Nordevang E, Hjalmar ML, et al. Treatment failure and dietary habits in women with breast cancer. J Natl Cancer Inst. 1993;85(1):32–36. [PubMed]
11. Zhang S, Folsom AR, Sellers TA, et al. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer. 1995;76(2):275–283. [PubMed]
12. McEligot AJ, Largent J, Ziogas A, et al. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer. 2006;55(2):132–140. [PubMed]
13. Hebert JR, Hurley TG, Ma Y. The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat. 1998;51(1):17–28. [PubMed]
14. Rohan TE, Hiller JE, McMichael AJ. Dietary factors and survival from breast cancer. Nutr Cancer. 1993;20(2):167–177. [PubMed]
15. Holmes MD, Stampfer MJ, Colditz GA, et al. Dietary factors and the survival of women with breast carcinoma. Cancer. 1999;86(5):826–835. [PubMed]
16. Kyogoku S, Hirohata T, Nomura Y, et al. Diet and prognosis of breast cancer. Nutr Cancer. 1992;17(3):271–277. [PubMed]
17. Kroenke CH, Fung TT, Hu FB, Holmes MD. Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(36):9295–9303. [PubMed]
18. Ingram D. Diet and subsequent survival in women with breast cancer. Br J Cancer. 1994;69(3):592–595. [PMC free article] [PubMed]
19. Rock CL, Flatt SW, Natarajan L, et al. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005 Sep 20;23(27):6631–6638. [PubMed]
20. Goodwin PJ, Ennis M, Pritchard KI, et al. Diet and breast cancer: Evidence that extremes in diet are associated with poor survival. J Clin Oncol. 2003;21(13):2500–2507. [PubMed]
21. Saxe GA, Rock CL, Wicha MS, Schottenfeld D. Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat. 1999;53(3):241–253. [PubMed]
22. Thomson CA, Flatt SW, Rock CL, et al. Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer. J Am Diet Assoc. 2002;102(6):801–808. [PubMed]
23. Jain M, Miller AB, To T. Premorbid diet and the prognosis of women with breast cancer. J Natl Cancer Inst. 1994;86(18):1390–1397. [PubMed]
**24. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The women’s healthy eating and living (WHEL) randomized trial. JAMA. 2007;298(3):289–298. This paper in a major general medical journal presents the results of the WHEL randomized trial (n=3088) reporting both breast cancer free survival and overall survival. Sub-group analyses are included for dietary pattern at the start of the trial. Trial had confirmed health status on 96% of both study groups after trial completion. The Kaplan-Meier curves from randomized groups with major biomarker-validated differences in dietary pattern were superimposed for both recurrence and mortality. [PMC free article] [PubMed]
25. Pierce JP, Faerber S, Wright FA, et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: The women’s healthy eating and living (whel) study. Control Clin Trials. 2002;23(6):728–756. [PubMed]
**26. Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: Interim efficacy results from the women’s intervention nutrition study. J Natl Cancer Inst. 2006;98(24):1767–1776. This paper is the only major publication to date on the WINS randomized trial (n=2437). The study was not funded through to its completion and outcomes are reported up to 12 months prior to the study’s stop date (mean 5 yr follow-up). It reports that changing energy from fat was marginally associated with prognosis. [PubMed]
27. Pierce JP, Newman VA, Natarajan L, et al. Telephone counseling helps maintain long-term adherence to a high-vegetable dietary pattern. J Nutr. 2007;137(10):2291–2296. [PMC free article] [PubMed]
28. Tang SC. Reducing the risk of distant metastases: A better end point in adjuvant aromatase inhibitor breast cancer trials? Cancer Invest. 2008;26(5):481–490. [PubMed]
*29. Rock CL, Flatt SW, Laughlin GA, et al. Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(3):614–620. This paper reports that circulating estrogens are a major predictor of which postmenopausal women will have an additional breast cancer event in the WHEL study. [PMC free article] [PubMed]
*30. Mortimer JE, Flatt SW, Parker BA, et al. Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat. 2008;108:421–426. This paper is the first to identify that women who do not report hot flashes after breast cancer treatment are at higher risk for early recurrence and death. [PMC free article] [PubMed]
31. Cuzick J. Hot flushes and the risk of recurrence - retrospective, exploratory results from the ATAC trial. SABC poster 2069; December 2007; San Antonio Breast Cancer Symposium. 2007.
32. Rock CL, Flatt SW, Thomson CA, et al. Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol. 2004;22(12):2379–2387. [PubMed]
**33. Gold EB, Pierce JP, Natarajan L, et al. A high vegetable, fruit, and fiber dietary pattern may influence breast cancer prognosis in women without hot flashes: A secondary analysis from the Women’s Healthy Eating and Living (WHEL) Study. J Clin Oncol. in press. This paper presents the WHEL study data by hot flash status and demonstrated that there was a major reduction in risk of distal events in the intervention group for those who did not have hot flashes at baseline (and hence were at increased risk). Numerous sensitivity analyses demonstrated the robustness of this finding.